Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
216 words
A method for manipulating nucleic acids so as to
optimize the binding characteristics of an encoded binding
protein to a particular ligand, said binding protein selected
from the group consisting of antibodies and T cell receptors
said method comprising the steps of: (a) providing two or more nucleic acids encoding
different binding proteins all having binding
affinity for said particular ligand, said binding
proteins selected from the group consisting of
antibodies and T cell receptors, said nucleic
acids having at least one set of splicing sites,
said set of splicing sites flanking opposite ends
of one or more encoded complementarity
determining regions (CDRs); (b) mixing said two or more nucleic acids to produce
a parent population of mixed nucleic acids
encoding said binding proteins; (c) randomly incorporating said one or more encoded
CDRs between said two or more nucleic acids
through said set of splicing sites to produce a
different population of nucleic acids than said
parent population, wherein at least one binding
protein encoded by said different population is
characterized by optimized binding
characteristics as compared with a member of the
parent population; and (d) selecting from said different population at least
one of the nucleic acids encoding a binding
protein characterized by optimized binding
characteristics as compared with a member of the
parent population.
Claim 2
Dependent Claim
24 words
The method of claim 1, wherein step (a) further
comprises synthesis of at least one nucleic acid encoding a
binding protein by enzymatic polymerization.
Claim 3
Dependent Claim
14 words
The method of claim 2, wherein said enzymatic
polymerization is a polymerase chain reaction.
Claim 4
Dependent Claim
22 words
The method of claim 1, wherein step (a) further
comprises chemical synthesis of at least one nucleic acid
encoding a binding protein.
Claim 5
Dependent Claim
81 words
The method of claim 1, wherein step (c) further
comprises: (c1) introducing at least one set of cleavage sites
within said parent population of mixed nucleic
acids at said splicing sites; (c2) cleaving said cleavage sites with a cleaving
reagent to produce termini at each splicing site
which are non-compatible for ligation and
releasing said one or more encoded CDRs from said
nucleic acids encoding binding proteins; and (c3) ligating said released encoded CDRs to said
nucleic acids encoding binding proteins.
Claim 6
Dependent Claim
40 words
The method of claim 2, wherein step (c) further
comprises annealing single strand regions of said splicing
sites between said two or more nucleic acids, said splicing
sites having sufficient nucleotide sequence identity between
complementary strands to allow specific hybridization.
Claim 7
Dependent Claim
14 words
The method of claim 6, wherein said two or more
nucleic acids are single-stranded.
Claim 8
Dependent Claim
40 words
The method of claim 4, wherein step (c) further
comprises annealing single stranded regions of said splicing
sites between said two or more nucleic acids said splicing
sites having sufficient nucleotide sequence identity between
complementary strands to allow specific hybridization.
Claim 9
Dependent Claim
14 words
The method of claim 8, wherein said two or more
nucleic acids are single-stranded.
Claim 10
Dependent Claim
11 words
The method of claim 1, wherein said binding
proteins are antibodies.
Claim 11
Dependent Claim
13 words
The method of claim 1, wherein said binding
proteins are T cell receptors.
Claim 12
Dependent Claim
16 words
The method of claim 5, wherein said set of
cleavage sites are restriction enzyme recognition sites.
Claim 13
Dependent Claim
25 words
The method of claim 12 wherein said restriction
enzyme recognition sites are selected from the group
consisting of Bst XI, Fok I and Dra III.
Claim 14
Dependent Claim
13 words
The method of claim 5, wherein said cleaving
reagent is a restriction enzyme.